Introduction
Ionic liquids (ILs) are salts with a melting point (Tm) or a glass transition (Tg) temperature below 100 °C [1]. Since the first description of air- and water-stable imidazolium ILs in 1992, the field has diverged into different applications. The first generation of ILs are solvents with tunable physical properties in chemical synthesis deploying their nonvolatile nature and thermal stability. The second generation of ILs are solvents tailoring chemical reactivity and solvation, thereby expanding chemical synthesis into liquid crystal development, biotechnology, analytics, extraction, and other applications. The third generation has been introduced as impacting biological properties for active pharmaceutical ingredients (API), e.g., when profiling APIs as IL through counterion design in an effort to control physical-chemical and pharmaceutical properties (e.g., dissolution rate) or providing additional functionality by using biologically active counterions (Fig. 1). ILs...
References
Hough WL, Smiglak M, Rodríguez H, Swatloski RP, Spear SK, Daly DT, Pernak J, Grisel JE, Carliss RD, Soutullo MD, Davis JJH, Rogers RD (2007) The third evolution of ionic liquids: active pharmaceutical ingredients. New J Chem 31:1429
Davis JH, Forrester KJ, Merrigan T (1998) Novel organic ionic liquids (OILs) incorporating cations derived from the antifungal drug miconazole. Tetrahedron Lett 39:8955–8958
Egorova KS, Seitkalieva MM, Posvyatenko AV, Khrustalev VN, Ananikov VP (2015) Cytotoxic activity of salicylic acid-containing drug models with ionic and covalent binding. ACS Med Chem Lett 6:1099–1104
Balk A, Holzgrabe U, Meinel L (2015) “Pro et contra” ionic liquid drugs – challenges and opportunities for pharmaceutical translation. Eur J Pharm Biopharm 94:291–304
Marrucho IM, Branco LC, Rebelo LP (2014) Ionic liquids in pharmaceutical applications. Annu Rev Chem Biomol Eng 5:527–546
Egorova KS, Gordeev EG, Ananikov VP (2017) Biological activity of ionic liquids and their application in pharmaceutics and medicine. Chem Rev 117:7132–7189
Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S (2011) Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 420:1–10
Stahl PH, Wermuth CG (2011) Handbook of pharmaceutical salts: properties, selection, and use, 2nd edn. Wiley-VCH, VHCA, Zurich/Weinheim
Jain N, Yang G, Machatha SG, Yalkowsky SH (2006) Estimation of the aqueous solubility of weak electrolytes. Int J Pharm 319:169–171
Anderson BD, Conradi RA (1985) Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug. J Pharm Sci 74:815–820
Florindo C, Araujo JM, Alves F, Matos C, Ferraz R, Prudencio C, Noronha JP, Petrovski Z, Branco L, Rebelo LP, Marrucho IM (2013) Evaluation of solubility and partition properties of ampicillin-based ionic liquids. Int J Pharm 456:553–559
Stoimenovski J, MacFarlane DR, Bica K, Rogers RD (2010) Crystalline vs ionic liquid salt forms of active pharmaceutical ingredients: a position paper. Pharm Res 27:521–526
Prakasha AS (2011) The counter ion: expanding excipient functionality. J Excip Food Chem 2:28–40
Higuchi WI (1967) Diffusional models useful in biopharmaceutics. J Pharm Sci 56:315–324
Serajuddin AT (2007) Salt formation to improve drug solubility. Adv Drug Deliv Rev 59:603–616
Sanan R, Kaur R, Mahajan RK (2014) Micellar transitions in catanionic ionic liquid–ibuprofen aqueous mixtures; effects of composition and dilution. RSC Adv 4:64877–64889
Balk A, Widmer T, Wiest J, Bruhn H, Rybak JC, Matthes P, Muller-Buschbaum K, Sakalis A, Luhmann T, Berghausen J, Holzgrabe U, Galli B, Meinel L (2015) Ionic liquid versus prodrug strategy to address formulation challenges. Pharm Res 32:2154–2167
Balk A, Wiest J, Widmer T, Galli B, Holzgrabe U, Meinel L (2015) Transformation of acidic poorly water soluble drugs into ionic liquids. Eur J Pharm Biopharm 94:73–82
Wiest J, Saedtler M, Bottcher B, Grune M, Reggane M, Galli B, Holzgrabe U, Meinel L (2018) Geometrical and structural dynamics of imatinib within biorelevant colloids. Mol Pharm 15:4470–4480
Wiest J, Saedtler M, Balk A, Merget B, Widmer T, Bruhn H, Raccuglia M, Walid E, Picard F, Stopper H, Dekant W, Luhmann T, Sotriffer C, Galli B, Holzgrabe U, Meinel L (2017) Mapping the pharmaceutical design space by amorphous ionic liquid strategies. J Control Release 268:314–322
McCrary PD, Beasley PA, Gurau G, Narita A, Barber PS, Cojocaru OA, Rogers RD (2013) Drug specific, tuning of an ionic liquid's hydrophilic–lipophilic balance to improve water solubility of poorly soluble active pharmaceutical ingredients. New J Chem 37:2196
Shadid M, Gurau G, Shamshina JL, Chuang BC, Hailu S, Guan E, Chowdhury SK, Wu JT, Rizvi SAA, Griffin RJ, Rogers RD (2015) Sulfasalazine in ionic liquid form with improved solubility and exposure. Med Chem Comm 6:1837–1841
Araújo JMM, Florindo C, Pereiro AB, Vieira NSM, Matias AA, Duarte CMM, Rebelo LPN, Marrucho IM (2014) Cholinium-based ionic liquids with pharmaceutically active anions. RSC Adv 4:28126–28132
Khan I, Kurnia KA, Mutelet F, Pinho SP, Coutinho JA (2014) Probing the interactions between ionic liquids and water: experimental and quantum chemical approach. J Phys Chem B 118:1848–1860
Jaitely V, Karatas A, Florence AT (2008) Water-immiscible room temperature ionic liquids (RTILs) as drug reservoirs for controlled release. Int J Pharm 354:168–173
Singhal D, Curatolo W (2004) Drug polymorphism and dosage form design: a practical perspective. Adv Drug Deliv Rev 56:335–347
Bucar DK, Lancaster RW, Bernstein J (2015) Disappearing polymorphs revisited. Angew Chem Int Ed Engl 54:6972–6993
Cojocaru OA, Kelley SP, Gurau G, Rogers RD (2013) Procainium acetate versus procainium acetate dihydrate: irreversible crystallization of a room-temperature active pharmaceutical-ingredient ionic liquid upon hydration. Cryst Growth Des 13:3290–3293
Newman AW, Reutzel-Edens SM, Zografi G (2008) Characterization of the “hygroscopic” properties of active pharmaceutical ingredients. J Pharm Sci 97:1047–1059
Stoimenovski J, MacFarlane DR (2011) Enhanced membrane transport of pharmaceutically active protic ionic liquids. Chem Commun (Camb) 47:11429–11431
Wang H, Gurau G, Shamshina J, Cojocaru OA, Janikowski J, MacFarlane DR, Davis JH, Rogers RD (2014) Simultaneous membrane transport of two active pharmaceutical ingredients by charge assisted hydrogen bond complex formation. Chem Sci 5:3449
Alves F, Oliveira FS, Schroder B, Matos C, Marrucho IM (2013) Synthesis, characterization, and liposome partition of a novel tetracycline derivative using the ionic liquids framework. J Pharm Sci 102:1504–1512
Reggane M, Wiest J, Saedtler M, Harlacher C, Gutmann M, Zottnick SH, Piechon P, Dix I, Muller-Buschbaum K, Holzgrabe U, Meinel L, Galli B (2018) Bioinspired co-crystals of Imatinib providing enhanced kinetic solubility. Eur J Pharm Biopharm 128:290–299
Zakrewsky M, Lovejoy KS, Kern TL, Miller TE, Le V, Nagy A, Goumas AM, Iyer RS, Del Sesto RE, Koppisch AT, Fox DT, Mitragotri S (2014) Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization. Proc Natl Acad Sci U S A 111:13313–13318
Kubota K, Shibata A, Yamaguchi T (2016) The molecular assembly of the ionic liquid/aliphatic carboxylic acid/aliphatic amine as effective and safety transdermal permeation enhancers. Eur J Pharm Sci 86:75–83
Miwa Y, Hamamoto H, Ishida T (2016) Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid. Eur J Pharm Biopharm 102:92–100
Miwa Y, Hamamoto H, Hikake S, Kuwabara Y (2013) A phase I, randomized, open-label, cross-over study of the pharmacokinetics, dermal tolerability, and safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in healthy volunteers. J Pain 14:S72
Kuwabara Y, Hamamoto H, Hikake S, Miwa Y (2013) A randomized, multi-Center, double-blind, placebo-controlled phase II/III trial to evaluate the efficacy, tolerability and safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the treatment of pain. J Pain 14:S73
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Saedtler, M., Meinel, L. (2019). Amorphous Ionic Liquid Strategies for Pharmaceutical Application. In: Zhang, S. (eds) Encyclopedia of Ionic Liquids. Springer, Singapore. https://doi.org/10.1007/978-981-10-6739-6_2-1
Download citation
DOI: https://doi.org/10.1007/978-981-10-6739-6_2-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6739-6
Online ISBN: 978-981-10-6739-6
eBook Packages: Springer Reference Chemistry and Mat. ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics